These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8479018)

  • 41. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
    Casabé A; Bechara A; Cheliz G; Romano S; Rey H; Fredotovich N
    Int J Impot Res; 1998 Mar; 10(1):5-9. PubMed ID: 9542684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracavernous injection of prostaglandin E1 in impotent men.
    Stackl W; Hasun R; Marberger M
    J Urol; 1988 Jul; 140(1):66-8. PubMed ID: 3379700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An improved vasoactive drug combination for a pharmacological erection program.
    Bennett AH; Carpenter AJ; Barada JH
    J Urol; 1991 Dec; 146(6):1564-5. PubMed ID: 1719248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic roles of intracavernosal papaverine.
    Goldstein I; Payton T; Padma-Nathan H
    Cardiovasc Intervent Radiol; 1988 Aug; 11(4):237-9. PubMed ID: 3147138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 49. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
    Sarosdy MF; Hudnall CH; Erickson DR; Hardin TC; Novicki DE
    J Urol; 1989 Mar; 141(3):551-3. PubMed ID: 2645420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.
    Moriel EZ; Rajfer J
    J Urol; 1993 May; 149(5 Pt 2):1299-300. PubMed ID: 8386779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep; 37(958):83-4. PubMed ID: 7674992
    [No Abstract]   [Full Text] [Related]  

  • 53. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
    Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N
    J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of vasoactive agents in the treatment of erectile impotence.
    Fried FA
    N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
    [No Abstract]   [Full Text] [Related]  

  • 55. Intracavernous self-injection for erectile failure.
    Ruutu M; Lindström BL; Virtanen J; Alfthan O
    Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
    Kiely EA; Bloom SR; Williams G
    Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intracavernous infusion of drugs].
    Bellorofonte C; Dell'Acqua S; Ruoppolo M; Zaatar C; Tombolini P
    Arch Ital Urol Nefrol Androl; 1992 Sep; 64(3):251-4. PubMed ID: 1439852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologically induced erections among geriatric men.
    Kerfoot WW; Carson CC
    J Urol; 1991 Oct; 146(4):1022-4. PubMed ID: 1895417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.
    Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kubota Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M
    J Urol; 1989 Feb; 141(2):323-5. PubMed ID: 2913354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.